BKPyV-DNAemia Affects Nearly One in Five Kidney Transplant Recipients
Physician's Weekly
JUNE 17, 2025
BKPyV-DNAemia is common after kidney transplant but rarely leads to graft loss or death, likely due to improved screening and management practices. Over the past decade, expert guidance has increasingly recommended BKPyV-DNAemia screening for kidney transplant recipients. in patients with HLA mismatch of 3/6 or 4/6, 2.06
59 
Let's personalize your content